Recent News

Click to view a history of all FHC News

Advanced Microelectrode Recording System Supports High Precision Targeting of Deep Brain Structures

FHC Launches Guideline 4000™ Software Release Version 1.4

Bowdoin, ME, December 11, 2009:  

FHC, leading neuroscience product manufacturer, announces an upgrade release for its neurosurgical microelectrode recording (MER) product, the Guideline 4000™ Neuromodulation Targeting System. The Guideline 4000™ supports microelectrode recording of neural activity and brain stimulation procedures.

(To read on, click here.)

  
 

 

 

  

click to view our Clinical Products Catalog

FHC Introduces the New microTargeting™ Star™ Drive

 

click to view our ad in an upcoming edition of "US Neurology"

 

 

On September 18th, leading neuroscience product manufacturer, FHC, received Food and Drug Administration clearance to market and sell its new microTargeting™  Star™ Drive in the United States. A CE mark awarded earlier in the month endorsed European promotion and sale. American and European FHC validation partners report a strong interest in the system for its smooth, stable and uncomplicated operation. (To read on, click here.)

Now cleared for use in Canada!
 
 
“Innovation through collaboration”

FHC Inc. 1201 Main Street, Bowdoin, ME 04287
Tel: 207-666-8190, Canada & US 1-800-326-2905,
Fax: 207-666-8292, email: fhcinc@fh-co.com